KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Net Margin (2016 - 2025)

Amgen has reported Net Margin over the past 17 years, most recently at 13.51% for Q4 2025.

  • Quarterly results put Net Margin at 13.51% for Q4 2025, up 661.0% from a year ago — trailing twelve months through Dec 2025 was 20.98% (up 875.0% YoY), and the annual figure for FY2025 was 20.98%, up 875.0%.
  • Net Margin for Q4 2025 was 13.51% at Amgen, down from 33.65% in the prior quarter.
  • Over the last five years, Net Margin for AMGN hit a ceiling of 352.07% in Q4 2022 and a floor of 1.52% in Q1 2024.
  • Median Net Margin over the past 5 years was 22.45% (2022), compared with a mean of 37.55%.
  • Biggest five-year swings in Net Margin: surged 32433bps in 2022 and later crashed -34271bps in 2023.
  • Amgen's Net Margin stood at 27.74% in 2021, then skyrocketed by 1169bps to 352.07% in 2022, then tumbled by -97bps to 9.36% in 2023, then decreased by -26bps to 6.9% in 2024, then surged by 96bps to 13.51% in 2025.
  • The last three reported values for Net Margin were 13.51% (Q4 2025), 33.65% (Q3 2025), and 15.6% (Q2 2025) per Business Quant data.